Mechanism of colchicine impairment of learning and memory, and protective effect of CGP36742 in mice

Brain Research

Volumn 750, Issue 1-2, 1997, Pages 53-58

  Yu, ZaiFang ^a,b   Cheng, GuanJun ^a   Hu, BenRong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; colchicine; GABA; GABA(B) receptor; GABA(B) receptor antagonist; glutamate; learning; memory

Indexed keywords

3 AMINOPROPYLBUTYLPHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; BACLOFEN; COLCHICINE; GLUTAMATE RECEPTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; HIPPOCAMPUS; HISTOLOGY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; AVOIDANCE LEARNING; CEREBRAL CORTEX; COLCHICINE; ELECTROSHOCK; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HIPPOCAMPUS; INFUSIONS, PARENTERAL; MALE; MEMORY; MICE; NEURONS; NEUROPROTECTIVE AGENTS; ORGANOPHOSPHORUS COMPOUNDS; RADIOLIGAND ASSAY; REACTION TIME; RECEPTORS, GABA-B; SYNAPTIC MEMBRANES;

EID: 0031057901     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01158-4     Document Type: Article

References (25)

1. 37849, a competitive NMDA receptor antagonist, prevents the behavioural and neurodegenerative effects of tetanus toxin in rat hippocampus, Mol. Neuropharmacol., 1 (1992) 45-51.
2. Bensimon, G. and Chermat, R., Microtubule disruption and cognitive defect: effect of colchicine on learning behavior in rats, Pharmacol. Biochem. Behav., 38 (1991) 141-145.
3. 35348 in the mouse, Cogn. Brain Res., 1 (1993) 135-139.
4. B receptor pharmacology, Annu. Rev. Pharmacol. Toxicol., 33 (1993) 109-147.
5. B receptor binding sites on rat whole brain synaptic membranes, Br. J. Pharmacol., 78 (1983) 191-206.
6. A receptor in Alzheimer's disease, a quantitative autoradiographic study, Neurology, 37 (1987) 1454-1459.
7. B receptor in the basal forebrain selectively impairs working memory of rats in the double Y-maze, Brain Res., 641 (1994) 29-38.
8. Divish, M.M., Sheftel, G., Boyle, A., Kalasapudi, V.D., Papolos, D.F. and Lachman, H.M., Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action, J. Neurosci. Res., 28 (1991) 40-48.
9. Francies, P.T., Sims, N.R. and Practer, A.W., Cortical pyramidal neurons loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives, J. Neurochem., 60 (1993) 1589-1604.
10. 3 hippocampal neurons, J. Neurophysiol., 72 (1994) 2360-2367.
11. B antagonists, J. Med. Chem., 38 (1995) 3313-3331.
12. 3H]glutamate binding, J. Neurochem., 48 (1987) 543-551.
13. Klunk, W.E., Debnath, M.L., McClure, R.J. and Pettegrew, J.W., Inactivity of phosphoethanolamine, an endogenous GABA analog decreased in Alzheimer's disease, at GABA binding sites, Life Sci., 56 (1995) 2377-2383.
14. Krogsaard, L.P., GABA and glutamate receptors as therapeutic target in neurodegenerative disorder, Pharmacol. Toxicol., 70 (1992) 95-104.
15. Lawlor, B.A. and Davis, K.L., Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease? Biol. Psychiatry, 31 (1992) 337-350.
16. Lowe, S.L., Bowen, D.M. and Francies, P.T., Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate enriched neurons in Alzheimer's diseases, Neuroscience, 38 (1990) 571-577.
17. B receptor in rat spinal cord detected by autoradiography, Eur. J. Pharmacol., 250 (1993) 153-156.
18. Nakagawa, Y., Nakamura, S., Kase, Y., Noguchi, T. and Ishihara, T., Colchicine lesions in the rat hippocampus mimic the alterations of several markers in Alzheimer's disease, Brain Res., 408 (1987) 57-64.
19. Ossowska, K., Disturbances in neurotransmission processes in aging and age-related diseases, Pol. J. Pharmacol., 45 (1993) 109-131.
20. B receptor binding sites in rat frontal cortex, Br. J. Pharmacol., 110 (1993) 724-735.
21. Sandberg, M., Butcher, S.P. and Hagberg, H., Extracellular overflow of neuroactive amino acids during severe insulin-induced hypolycema: in vivo dialysis of the rat hippocampus, J. Neurochem., 22 (1987) 471-480.
22. Wang, G.P., Lu, H.X., Zhang, W.N., Wu, F.M. and Qing, G.Q., Hippocampal microinfusion method and its use in mice, Chinese Pharmacol. Bull., 9 (1993) 73-74.
23. Wood, J.D., Evaluation of a synaptosomal model for monitoring in vivo changes in the GABA and glutamate content of nerve endings, Int. J. Biochem., 13 (1981) 543-548.
24. 36742 in mice, Chinese J. Pharmacol. Toxicol. (1997) in press.
25. Zhang, J.T. and Saito, H., Studies on susceptibilities to the amnestic effects of 12 chemicals on passive avoidance responses in mice: comparison between step down and step through tests, Acta Pharm. Sinica, 21 (1986) 12-19.